Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review (English)
Free access
- New search for: Madsen, Marie Lindhard
- New search for: Due, Hanne
- New search for: Ejskjær, Niels
- New search for: Jensen, Paw
- New search for: Madsen, Jakob
- New search for: Dybkær, Karen
- New search for: Madsen, Marie Lindhard
- New search for: Due, Hanne
- New search for: Ejskjær, Niels
- New search for: Jensen, Paw
- New search for: Madsen, Jakob
- New search for: Dybkær, Karen
In:
Cancer Chemotherapy and Pharmacology
;
84
, 3
; 471-485
;
2019
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
-
Contributors:Madsen, Marie Lindhard ( author ) / Due, Hanne ( author ) / Ejskjær, Niels ( author ) / Jensen, Paw ( author ) / Madsen, Jakob ( author ) / Dybkær, Karen ( author )
-
Published in:Cancer Chemotherapy and Pharmacology ; 84, 3 ; 471-485
-
Publisher:
- New search for: Springer Berlin Heidelberg
- New search for: Springer
-
Place of publication:Berlin
-
Publication date:2019
-
ISSN:
-
ZDBID:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
- New search for: 44.40 / 44.38
- Further information on Basic classification
-
Keywords:
-
Classification:
-
Source:
Table of contents – Volume 84, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 453
-
The role of thioredoxin system in cancer: strategy for cancer therapyJia, Jin-Jing / Geng, Wen-Shuo / Wang, Zhan-Qi / Chen, Lei / Zeng, Xian-Si et al. | 2019
- 471
-
Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic reviewMadsen, Marie Lindhard / Due, Hanne / Ejskjær, Niels / Jensen, Paw / Madsen, Jakob / Dybkær, Karen et al. | 2019
- 487
-
Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanesvan Eijk, Maarten / Boosman, René J. / Schinkel, Alfred H. / Huitema, Alwin D. R. / Beijnen, Jos H. et al. | 2019
- 501
-
Application of time-dependent modeling for the exposure–efficacy analysis of ceritinib in untreated ALK-rearranged advanced NSCLC patientsLau, Yvonne Y. / Gu, Wen / Ho, Yu-Yun / Hong, Ying / Zhang, Xinrui / Urban, Patrick et al. | 2019
- 513
-
Electrophysiologic evaluation of facial nerve functions after oxaliplatin treatmentYigit, Oznur / Kulak Kayikci, Mavis Emel / Temucin, Cagri Mesut / Sarac, Sarp / Erman, Mustafa / Belgin, Erol et al. | 2019
- 521
-
BRAF mutation status might contribute an effect on both disease-free and overall survival in stage III cutaneous melanomas treated with intermediate dose interferon-alphaTas, Faruk / Erturk, Kayhan et al. | 2019
- 527
-
In vitro evaluation of FL118 and 9-Q20 cytotoxicity and cellular uptake in 2D and 3D different cell modelsWeng, Qi / Zhou, Leilei / Xia, Lihua / Zheng, Yixin / Zhang, Xiangli / Li, Fengzhi / Li, Qingyong et al. | 2019
- 539
-
Pharmacokinetic and exposure–response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancerKirschbrown, Whitney P. / Wang, Bei / Nijem, Ihsan / Ohtsu, Atsushi / Hoff, Paulo M. / Shah, Manish A. / Shen, Lin / Kang, Yoon-Koo / Alsina, Maria / Girish, Sandhya et al. | 2019
- 551
-
Identification of dinactin, a macrolide antibiotic, as a natural product-based small molecule targeting Wnt/β-catenin signaling pathway in cancer cellsHussain, Aehtesham / Dar, Mohd Saleem / Bano, Nasima / Hossain, Md Mehedi / Basit, Rafia / Bhat, Aadil Qadir / Aga, Mushtaq A. / Ali, Sabeena / Hassan, Qazi Parvaiz / Dar, Mohd Jamal et al. | 2019
- 561
-
Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional studyShiota, Masaki / Nakamura, Motonobu / Yokomizo, Akira / Tomoda, Toshihisa / Sakamoto, Naotaka / Seki, Narihito / Hasegawa, Shuji / Yunoki, Takakazu / Harano, Masahiko / Kuroiwa, Kentaro et al. | 2019
- 567
-
A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancerGoel, Sanjay / Swami, Umang / Kumar, Kirushna / Dittrich, Christian / Reyderman, Larisa / Jain, Minish / Aisner, Joseph / Song, James / Petrylak, Daniel P. et al. | 2019
- 579
-
Spatial memory deficits in mice induced by chemotherapeutic agents are prevented by acetylcholinesterase inhibitorsPhilpot, Rex M. / Ficken, M. / Johns, B. E. / Engberg, M. E. / Wecker, L. et al. | 2019
- 591
-
Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot studyPintova, Sofya / Dharmupari, Sirish / Moshier, Erin / Zubizarreta, Nicole / Ang, Celina / Holcombe, Randall F. et al. | 2019
- 599
-
Incidence of and risk factors for cardiotoxicity after fluorouracil-based chemotherapy in locally advanced or metastatic gastric cancer patientsJin, Xuan / Bai, Yu / Gao, Lan / Wu, Shikai et al. | 2019
- 609
-
A high AR:ERα or PDEF:ERα ratio predicts a sub-optimal response to tamoxifen therapy in ERα-positive breast cancerCao, Lu / Xiang, Guomin / Liu, Fang / Xu, Cong / Liu, Jing / Meng, Qingxiang / Lyu, Shuhua / Wang, Shuling / Niu, Yun et al. | 2019
- 621
-
Assessment of the effect of erdafitinib on cardiac safety: analysis of ECGs and exposure–QTc in patients with advanced or refractory solid tumorsValade, Elodie / Dosne, Anne-Gaëlle / Xie, Hong / Kleiman, Robert / Li, Lilian Y. / Perez-Ruixo, Juan José / Ouellet, Daniele et al. | 2019
- 635
-
Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression responseXu, Xing / Zheng, Guoliang / Zhang, Tao / Zhao, Yan / Zheng, Zhichao et al. | 2019
- 647
-
The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreatic cancer compared with younger patientsIshimoto, Utako / Kinoshita, Akiyoshi / Hirose, Yuki / Shibata, Keiko / Ishii, Ayako / Shoji, Ryo / Yokota, Takeharu / Iwaku, Akira / Mizuno, Yusuke / Koike, Kazuhiko et al. | 2019
- 655
-
Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot studyKotake, Mie / Imai, Hisao / Kaira, Kyoichi / Fujisawa, Tomomi / Yanagita, Yasuhiro / Minato, Koichi et al. | 2019
- 661
-
Rituximab dosing in hematological malignancies: an old question, revisitedMorcos, Peter N. / Boehnke, Axel / Valente, Nancy / Mager, Donald E. et al. | 2019
- 667
-
Correction to: Population pharmacokinetics of PF‑05280014 (a trastuzumab biosimilar) and reference trastuzumab ($ Herceptin^{®} $) in patients with HER2‑positive metastatic breast cancerChen, Xiaoying / Li, Cheryl / Ewesuedo, Reginald / Yin, Donghua et al. | 2019